Table 3.
Multivariate analysis of LDH, leukocytes, bilirubin, ECOG and chemotherapy.
| Covariate | b | SE | Wald | p | Exp(b) | 95% Clof Exp(b) |
|---|---|---|---|---|---|---|
| ABD | −1.8059 | 0.7569 | 5.6925 | 0.0170 * | 0.1643 | 0.0373 to 0.7244 |
| Therapy | −0.9249 | 0.8374 | 1.2196 | 0.2694 | 0.3966 | 0.0768 to 2.0473 |
| ECOG group | 0.2216 | 0.2983 | 0.5522 | 0.4574 | 1.2481 | 0.6956 to 2.2394 |
| Leukocytes | 0.2050 | 0.3053 | 0.4507 | 0.5020 | 1.2275 | 0.6747 to 2.2331 |
| LDH groups | 0.4695 | 0.3243 | 2.0950 | 0.1478 | 1.5991 | 0.8468 to 3.0198 |
| Bilirubin | 0.4134 | 0.5881 | 0.4942 | 0.4821 | 1.5120 | 0.4775 to 4.7878 |
ABD—adequate bilirubin decline, Therapy—chemotherapy, LDH—lactate dehydrogenase, Leukocytes—white blood cells, ECOG—Eastern Cooperative Oncology Group. *, statistically significant difference.